AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Episode #190: August 2022 Research Review
Barbell Medicine Podcast
Obesity and GLP1 Receptor Agonists
These are medicines that we're having increasing experience with, both in the context of diabetes where they were originally studied and approved and more recently obesity as well. So it falls into a class called GLP1 receptor agonist or glucagon like peptide one receptor agonists. And this is basically hitting a receptor that is targeted by hormones that are made in our gut already. They impact the rate that our stomach empties and kind of moves food along in the GI tract. It can increase the release of insulin to handle the effects of the meal as it is digested and absorbed. Then I think most interestingly and most importantly, it has some effects in the brain as it relates to appetite and
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode